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Summary 
 
 A recent report from the laboratory of Heidi McBride (McGill University) presents 
a role for mitochondria in the de novo biogenesis of peroxisomes in mammalian cells (1).  
Peroxisomes are essential organelles responsible for a wide variety of biochemical 
functions, from the generation of bile, to plasmalogen synthesis, reduction of peroxides, 
and the oxidation of very long chain fatty acids (2). Like mitochondria, peroxisomes 
proliferate primarily through growth and division of pre-existing peroxisomes (3-6). 
However, unlike mitochondria, peroxisomes do not fuse (5,7); further, and perhaps most 
importantly, they can also be born de novo, a process thought to occur through the 
generation of pre-peroxisomal vesicles that originate from the endoplasmic reticulum 
(reviewed in (8,9). De novo peroxisome biogenesis has been extensively studies in 
yeast, with a major focus on the role of the ER in this process. Comprehensive studies in 
mammalian cells are, however, scarce (5,10-12). By exploiting patient cells lacking 
mature peroxisomes, Sugiura et al. (1) now assign a role to ER and mitochondria in de 
novo mammalian peroxisome biogenesis by showing that the formation of immature pre-
peroxisomes occurs through the fusion of Pex3- / Pex14-containing mitochondria-
derived vesicles with Pex16-containing ER-derived vesicles. 
 
Peroxisome biogenesis in yeast and mammals, version 1.0 
 
Since their discovery in the early 1950s, the origin and formation of peroxisomes 
has been extensively studied and hotly debated. It is now widely accepted that 
peroxisomes are semi-autonomous organelles, which multiply by growth and division, 
but depend on the ER for supply of other essential components such as lipids. There is 
also general agreement that the ER contributes to the de novo formation of 
peroxisomes, in particular in cells without pre-existing peroxisomes. Current models 
derived from studies in different yeast species suppose that the core peroxisomal import 
machinery is first targeted to the ER (or structures close to the ER), and enriched in pre-
peroxisomal vesicles, which fully assemble the peroxisomal import machinery, thereby 
allowing continued growth and division (8,13,14). This model is not without controversy, 
and differences exist between fungal models, including H. polymorpha, Y. lipolytica, S. 
cerevisiae and S. pombe (4,15-18). Importantly, the mechanisms identified within the 
fungal model systems may not fully apply to mammalian cells, given the major 
evolutionary distance.  For example, an essential component of the mammalian import 
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machinery for peroxisomal membrane proteins (PMPs), Pex16 (19), is absent in baker’s 
yeast (20). In addition, while both yeast and mammalian cells contain Pex3, another 
essential PMP import receptor (21,22), in the absence of peroxisomes the fungal and 
mammalian forms of Pex3 target different organelles: in yeast, Pex3 seems to be routed 
to the ER, where it can function to facilitate de novo biogenesis; instead, in mammals 
Pex3 targets mitochondria (8,23). In fact, in cells lacking peroxisomes, it is not just Pex3 
that targets mitochondria, but also many other peroxisomal membrane proteins such as 
Pex14 (24). The mis-targeting of peroxisomal proteins to the mitochondria was largely 
assumed to be an artifact due to loss of PMP import and/or overexpression of PMPs, 
and it was not considered that a peroxisomal membrane protein at mitochondria could 
have any important functional role in peroxisome biology.  Instead, the field focused 
mostly on the ER, possibly because Pex16 in mammalian cells is routed to the ER when 
peroxisomes are absent, a finding that was more “consistent” with the yeast Pex3 
insertion into the ER (reviewed in (9)).  That said, the focus on an ER resident protein 
like Pex16, rather than on the “partially mitochondrial” Pex3, made sense also in light of 
the fact that there was no known mechanism that could make a bona fide peroxisomal 
membrane protein exit from the mitochondrion and be selectively sorted and delivered to 
a nascent pre-peroxisome.  In contrast, the ER, being a professional sorting station, 
made it straightforward to envisage a model where peroxisomal proteins like Pex16 
initiate peroxisomal biogenesis solely from the ER.  However, in 2008 Neuspiel and 
colleagues from the McBride lab identified a novel vesicular transport route between the 
mitochondria and a sub-population of peroxisomes within mammalian cells (25), making 
it theoretically possible that other types of vesicles might exist to carry cargo to other 
organelles, like pre-peroxisomes (1). It is from this starting point, that Sugiura et al. 
revisited the molecular mechanisms of de novo peroxisomal biogenesis in mammalian 
cells and identified a possible pathway for mitochondria-derived vesicles to carry 
mitochondrial Pex3 to pre-peroxisomes. 
Mammalian peroxisome biogenesis, version 2.0 
 
 Mammalian peroxisome biogenesis can be studied using a genetic approach that 
is based on utilizing fibroblast cell lines derived from patients suffering from Zellweger 
syndrome, a rare autosomal recessive disease characterized by a lack of functional 
peroxisomes and early neonatal lethality (26,27). In their study, Sugiura et al. used 
Zellweger patient’s fibroblasts that lacked peroxisomes due to the loss of either Pex3 or 
Pex16, two essential components required for the import of peroxisomal membrane 
proteins and membrane biogenesis (28,29). Here, the authors showed that infection of 
these cells with adenovirus over-expressing the missing peroxin (Pex3 or Pex16) 
reconstitutes the formation of peroxisomes.  Using confocal imaging and immunogold 
electron microscopy, Sugiura et al. provides evidence that Pex3 is first inserted into the 
mitochondrial outer membrane, and then exits the mitochondrion within vesicular 
structures.  The study also shows that endogenous Pex14, an integral membrane 
protein for luminal peroxisomal matrix import, targets mitochondria in these cells, and is 
enriched within Pex3-positive vesicles that bud from mitochondria.  Since mitochondrial 
vesicles can carry cargo to the lysosome (30), Sugiura et al. tested whether Pex3 and 
Pex14 within vesicular carriers may be destined for degradation.  However, this was not 
the case since inhibition of lysosomal transport with bafilomycin did not affect the rescue 
of peroxisomal biogenesis, and did not lead to an accumulation of Pex3-positive vesicles 
or protein.  Instead, the Pex3-positive vesicles stained with endogenous peroxisomal 
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markers like PMP70 and catalase, indicating that the Pex3-containing vesicles released 
from mitochondria matured into import competent peroxisomes. Interestingly, de novo 
peroxisome biogenesis was shown to involve a second class of vesicles, this time 
emerging from the ER, carrying Pex16, the partner of Pex3 for membrane protein 
import. Video microscopy and immunogold electron microscopy data showed that Pex16 
vesicles, derived from the ER, partially targeted the mitochondrial surface, where they 
appeared to have the ability to fuse either directly with mitochondria at sites where Pex3 
was highly enriched, or with Pex3/Pex14 positive vesicles. The compartmentalization of 
Pex16 within the ER and Pex3/Pex14 within the mitochondria may ensure that the 
parental organelles will not gain import competence for peroxisomal matrix proteins, 
thereby maintaining their functional identity.  Such “double organellar origin” of the 
peroxisome is an interesting finding that may establish a new paradigm in organellar 
biogenesis.  In this context, it will be very important to follow the transit of endogenous 
Pex3 during de novo peroxisome biogenesis; other interesting aspects include the 
mechanism of fusion between Pex16 and Pex3/Pex14 vesicles, and the process of 
maturation into peroxisomes. 
 
It should be noted that Pex3-dependent de novo peroxisome biogenesis from 
mitochondrial membranes has been observed in the yeast S. cerevisiae. Rucktaschel et 
al. (31) generated a mitochondrial Pex3 by fusion with the mitochondrial targeting signal 
of Tom20p. Expression of mitochondrial Pex3 in Pex3-deficient cells, which lack 
functional peroxisomes, resulted in the de novo formation of import-competent 
peroxisomes. These findings confirm that Pex3p-containing mitochondria in yeast and 
mammalian cells can serve as source for de novo peroxisome biogenesis. Rucktaschel 
and colleagues also concluded that natural or artificial targeting of Pex3p to any 
endomembrane may initiate peroxisome formation. It is thus likely that the specific 
physicochemical properties of peroxisomal membrane proteins allow targeting to other 
endomembranes, preferentially ER or mitochondria, when peroxisomal membranes are 
absent and/or the PMP import machinery is compromised. The physicochemical 
properties of PMPs may differ between organisms and species resulting in different 
affinities for organelle import receptors and chaperones, and may explain the 
preferential ER or mitochondrial localization in yeast and mammalian cells. The core 
import machinery may then exploit these membranes for the generation of pre-
peroxisomal structures in order to obtain lipids/membrane for peroxisome formation. It 
will be interesting to investigate if these processes are linked to quality control 
mechanisms at organelle membranes to specifically re-localize membrane proteins with 
altered location. 
 
In peroxisome-containing wild-type fibroblasts, Pex3 localizes exclusively to 
peroxisomes, and peroxisome biogenesis occurs through growth and division of pre-
existing organelles. In their study, Sugiura et al. visualized Pex3 targeting to the 
mitochondria not just in human fibroblast cells derived by Zellweger patients, but also in 
control cells under conditions of peroxisome loss. It is known that Pex3 expression can 
trigger the selective, ubiquitination-linked degradation of peroxisomes (pexophagy) (32). 
Although this was only observed in a small percentage of control cells, it shows that the 
machinery and processes for Pex3 import into mitochondria exist in wild type cells and 
can be triggered upon physiological stress.  
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This leads to the important question about the physiological importance and 
function of de novo peroxisome biogenesis. In yeast cells, which contain few 
peroxisomes, de novo biogenesis may help to overcome loss of peroxisomes due to the 
inability to properly distribute peroxisomes to the budding daughter cell (4,33). In the 
mammalian system, it is almost completely unknown how, whether or when de novo 
peroxisome biogenesis may occur. De novo peroxisome biogenesis may be a rare event 
because it is coupled with pexophagy, possibly as a mechanism to restore the 
population of peroxisomes that inhabit a cell. Within such scenario, it would be important 
to learn whether de novo biogenesis is restricted to select physiological/metabolic states 
of the cell; also whether de novo peroxisome biogenesis is a constitutive or dominant 
process only in certain cell types, a possibility that would allow to clarify the etiology of a 
number of diseases that have dysregulated peroxisome activity.  
 
 In searching for the molecular machinery and regulation of Pex3 incorporation 
into pre-peroxisomal vesicles, Sugiura et al. conducted a number of experiments in 
which they downregulated candidate proteins either by silencing them or by using a 
pharmacological approach.  These studies revealed a number of important findings.  
First, the fact that the addition of the proteasomal inhibitor MG132 led to a block in Pex3 
exit from mitochondria, and an inhibition of peroxisomal biogenesis, leading the authors 
to conclude that Pex3 must exit the mitochondria to generate new peroxisomes. Here, 
addition of MG132 caused a robust accumulation of Pex3, indicating a rapid, ubiquitin- 
and proteasome-dependent turnover of Pex3 in both the Zellweger and control human 
fibroblasts; instead, Pex14 remained stably expressed.  This implies that Pex3, whether 
it resides in the mitochondria or in the peroxisome, is subject to regulated ubiquitination, 
which leads to the retrotranslocation of the single-pass transmembrane protein into the 
cytosol for degradation by the proteasome. Ubiquitin-dependent turnover of Pex3 was 
previously observed in the yeast H. polymorpha (34), and ubiquitination of Pex5, a 
receptor for the import of peroxisomal matrix proteins, is essential for its recycling form 
the peroxisomal membrane (35). That specific peroxisomal membrane proteins are 
selectively targeted for ubiquitination opens a series of new questions, including the 
identity and regulation of the ligases; further, it highlights the importance of addressing 
how such rapid turnover on Pex3 differentially impacts on its function as an import 
protein and as a pexophagy receptor.  
 
 Lastly, silencing experiments showed that Pex3 exit from mitochondria is 
independent of the core mitochondrial (and peroxisomal) fission GTPase Drp1 as well as 
of Vps35. Similarly, the GTPases Vps1p and Dnm1p, two proteins required for 
peroxisome fission in yeast, were not required for Pex3-dependent de novo peroxisome 
biogenesis from mitochondrial membranes in the yeast S. cerevisiae (31). These are 
findings that, on one hand, are consistent with previous studies from the McBride 
laboratory in which it was shown that the budding of mitochondria-derived vesicles from 
the organelle did not require Drp1 (25). However, on the other hand, the fact that Vps35 
is not required for Pex3 mobilization from the mitochondria is intriguing because they 
previously showed that the protein, which is a component of the retromer complex, 
regulates the exit of MAPL (a.k.a. MUL1/MULAN) into vesicles that are targeted to a 
sub-population of peroxisomes (36). This suggests that mitochondria might be budding 
out vesicles via Vps35-dependent and Vps35-independent mechanisms. Consistent with 
this possibility, Sugiura et al. showed electron microscopy data indicating that Pex3-
containing vesicles are structurally different from MAPL-containing ones. More 
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specifically, MAPL-containing structures are strictly 70-100 nm in diameter, and contain 
both inner and outer mitochondrial membranes; instead, Pex3-containing structures are 
more pleotropic in size, up to 250 nm in diameter, do not appear to have a spherical 
shape, are electroluscent, and contain at least the outer mitochondrial membrane 
(sometime both membranes). This finding highlights the flexibility of mitochondria in 
segregating different cargoes through distinct molecular mechanisms of vesicle 
biogenesis, which ultimately results in vesicles that carry out different functions (37). To 
date mitochondria derived vesicles (MDV) are known to carry mitochondrial proteins to 
peroxisomes (25,36), oxidized proteins to the lysosome in a PINK1/Parkin dependent 
manner (30,38,39), mitochondrial antigens to the lysosome in a process inhibited by 
PINK1/Parkin (38,40), oxidized mtDNA for cellular release within neutrophils (41), and, 
lastly, the protein MAPL to a subpopulation of peroxisomes in a retromer-dependent 
manner (25,36). The McBride lab now extend MDV biology by showing that they 
generate pre-peroxisomal vesicles containing Pex3 (1). Clearly, the extent and function 
of cargoes that exit mitochondria within vesicular structures is likely to continue to 
expand, and is poised to have major impact on several fields of cell biology. 
 
Coupling the biology of mitochondria to that of peroxisome: possible impacts on 
disease 
 
The identification of cooperative and essential roles for both the ER and 
mitochondria in de novo peroxisome biogenesis opens entirely new and exciting 
avenues for future research.  One critical initial step will be the development of 
experimental paradigms to study de novo peroxisomal biogenesis in complex 
mammalian physiology. To this end, it is essential to understand the functional links 
between the peroxisomes, mitochondria, and the ER; mitochondria and peroxisomes 
cooperate in several metabolic and signaling tasks, and even share common machinery 
for their division (6,42). Furthermore, the transcriptional regulation of mitochondria and 
peroxisomal biogenesis is also shared through the PGC1alpha and the PPAR system 
(43,44). Last but not least, they both rely on the ER for lipid biosynthesis, and they both 
form membrane contact sites with the ER (45-49). For deciphering the cellular signals 
that may trigger de novo peroxisomal biogenesis, one can turn to the cell-type specific 
biochemical processes that utilize this metabolic triad of organelles. This includes 
hepatocytes, where ER-derived cholesterol is used to generate bile acids using 
enzymes found within all three organelles; within this context, it is possible that the rapid 
expansion of hepatocytes during development or injury may require de novo peroxisome 
biogenesis.  Similarly, in the central nervous system, 70 mol% of the myelin sheets is 
composed by the ether lipid plasmalogen; this lipid is made by oligodendrocytes, in the 
peroxisomes, using phosphatidylethanolamine, which is generated in the mitochondria 
from ER-derived phosphatidyl serine (50) at mitochondria-ER contact sites (48,51-54). 
This intimate metabolic cycle requires a unique homeostatic niche that may provide an 
opportunity to better understand the mechanisms and physiology of de novo 
peroxisomal biogenesis.   
 
This and previous studies indicate that mitochondrial function may be directly 
coupled to that of the peroxisome; by implication, mitochondrial dysfunctions might also 
impact on peroxisome activity and vice versa (55).  We have witnessed a renaissance in 
mitochondrial cell biology over the last decade, particularly with the established links to 
Michael Schrader & Luca Pellegrini                                                                        Cell Death & Differentiation, Perspective 
 6
diseases like Parkinson’s (56), Alzheimer’s (57,58), cancer (59), metabolic syndromes, 
and a host of rare diseases that, together, afflict millions of people worldwide.  In 
addition, new links between mitochondrial ultrastructure, dynamics, and inter-organellar 
contacts with changes in cell metabolism have expanded the field. Although it has been 
known that there is extensive metabolic flux between the mitochondria and peroxisome, 
this knowledge hasn’t yet led to significant experimental examination of the contribution 
of peroxisomal dysfunction to these diseases.  Peroxisomal disorders like Zellweger 
syndrome or adrenoleukodystrophy are linked to neurological defects, and it is 
conceivable that peroxisomal dysfunction may play an important role in 
neurodegeneration and aging.  In this respect, it is not clear, for example, whether there 
is a specific role for peroxisomes within axons and dendrites. It is commonly believed 
that there are few peroxisomes in axons, which instead appear to be segregated into 
dendrites:  why is this, and how is it regulated?  What does it mean for the metabolism 
within the axon?  Similarly, peroxisomes are central to the function of oligodendrocytes, 
but have not been actively studied in the process of Multiple sclerosis, or during 
oligodendrocyte degeneration and regeneration processes. Indeed, a primary phenotype 
of Zellweger patients is a loss of myelination.  Even within liver disease peroxisomes are 
generally seen as a passive generator of bile acids, without a major contribution to the 
etiology of disease.  It has only been a few years since we learned of the molecular 
importance of mitophagy in disease, and we imagine that Sugiura et al. will open a 
similar resurgence of interest in peroxisomal biology. 
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The making of a mammalian peroxisome, version 2.0: mitochondria get into the mix
Figure 1: an hypothetical model depicting some of the steps that might be involved into the 
formation of ER-derived and mitochondria-derived vescicles; their fusion generates  a 
pre-peroxisome, which then matures into a peroxisome. 
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